{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:37:35Z","timestamp":1795243055272,"version":"4.10.3"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11882-024-01186-2","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T04:04:15Z","timestamp":1733371455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5761-7018","authenticated-orcid":false,"given":"Eugenio","family":"De Corso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6898-688X","authenticated-orcid":false,"given":"Peter W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4852-229X","authenticated-orcid":false,"given":"Wytske J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-0192","authenticated-orcid":false,"given":"Ludger","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-2379","authenticated-orcid":false,"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0732-9728","authenticated-orcid":false,"given":"Glenis K.","family":"Scadding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3774-2959","authenticated-orcid":false,"given":"Martin","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-6606","authenticated-orcid":false,"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-5007","authenticated-orcid":false,"given":"Joaquim","family":"Mullol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"1186_CR1","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin22.344","author":"PW Hellings","year":"2022","unstructured":"Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhin. 2022. https:\/\/doi.org\/10.4193\/Rhin22.344.","journal-title":"Rhin"},{"issue":"3","key":"1186_CR2","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ, Viskens A-S, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS\/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61(3):194\u2013202. https:\/\/doi.org\/10.4193\/Rhin22.489.","journal-title":"Rhinology"},{"key":"1186_CR3","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin23.341","author":"J Mullol","year":"2024","unstructured":"Mullol J, Sastre J, Dom\u00ednguez-Ortega J, Blanco- Aparicio M, Castillo Vizuete JA, Alobid I, et al. Prevalence of chronic rhinosinusitis without\/with nasal polyps according to severity in Spain. Rhinology. 2024. https:\/\/doi.org\/10.4193\/Rhin23.341.","journal-title":"Rhinology"},{"key":"1186_CR4","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin23.415","author":"WJ Fokkens","year":"2024","unstructured":"Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, Von Buchwald C, et al. EPOS2020\/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024. https:\/\/doi.org\/10.4193\/Rhin23.415.","journal-title":"Rhinology"},{"key":"1186_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4193\/Rhin23.335","volume":"61","author":"AR Sedaghat","year":"2023","unstructured":"Sedaghat AR, Fokkens WJ, Lund VJ, Hellings PW, Kern RC, Reitsma S, et al. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study. Rhinology. 2023;61:519\u201330. https:\/\/doi.org\/10.4193\/Rhin23.335.","journal-title":"Rhinology"},{"key":"1186_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41577-022-00735-y","volume":"23","author":"R Ebina-Shibuya","year":"2023","unstructured":"Ebina-Shibuya R, Leonard WJ. Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol. 2023;23:24\u201337. https:\/\/doi.org\/10.1038\/s41577-022-00735-y.","journal-title":"Nat Rev Immunol"},{"key":"1186_CR7","doi-asserted-by":"publisher","first-page":"12725","DOI":"10.3390\/ijms241612725","volume":"24","author":"S Smolinska","year":"2023","unstructured":"Smolinska S, Antol\u00edn-Am\u00e9rigo D, Popescu F-D, Jutel M. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma. IJMS. 2023;24:12725. https:\/\/doi.org\/10.3390\/ijms241612725.","journal-title":"IJMS"},{"key":"1186_CR8","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","volume":"384","author":"A Menzies-Gow","year":"2021","unstructured":"Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe. Uncontrolled Asthma N Engl J Med. 2021;384:1800\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2034975.","journal-title":"Uncontrolled Asthma N Engl J Med"},{"key":"1186_CR9","doi-asserted-by":"publisher","first-page":"2201193","DOI":"10.1183\/13993003.01193-2022","volume":"61","author":"GM Gauvreau","year":"2023","unstructured":"Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet L-P, Cockcroft DW, Davis BE, et al. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma. Eur Respir J. 2023;61:2201193. https:\/\/doi.org\/10.1183\/13993003.01193-2022.","journal-title":"Eur Respir J"},{"key":"1186_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s40265-022-01679-2","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy SM. Tezepelumab: First Approval. Drugs. 2022;82:461\u20138. https:\/\/doi.org\/10.1007\/s40265-022-01679-2.","journal-title":"Drugs"},{"key":"1186_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4193\/Rhin17.255","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Vandeplas G, Huynh TMT, Joish VN, Mannent L, Tomassen P, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhin. 2019;57:32\u201342. https:\/\/doi.org\/10.4193\/Rhin17.255.","journal-title":"Rhin"},{"key":"1186_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00408-023-00603-z","volume":"201","author":"AH Khan","year":"2023","unstructured":"Khan AH, Gouia I, Kamat S, Johnson R, Small M, Siddall J. Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis. Lung. 2023;201:57\u201363. https:\/\/doi.org\/10.1007\/s00408-023-00603-z.","journal-title":"Lung"},{"key":"1186_CR13","doi-asserted-by":"publisher","first-page":"105947","DOI":"10.1016\/j.rmed.2020.105947","volume":"166","author":"GW Canonica","year":"2020","unstructured":"Canonica GW, Malvezzi L, Blasi F, Paggiaro P, Mantero M, Senna G, et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med. 2020;166:105947. https:\/\/doi.org\/10.1016\/j.rmed.2020.105947.","journal-title":"Respir Med"},{"key":"1186_CR14","doi-asserted-by":"publisher","first-page":"e0127228","DOI":"10.1371\/journal.pone.0127228","volume":"10","author":"K H\u00e5kansson","year":"2015","unstructured":"H\u00e5kansson K, Bachert C, Konge L, Thomsen SF, Pedersen AE, Poulsen SS, et al. Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported. PLoS ONE. 2015;10:e0127228. https:\/\/doi.org\/10.1371\/journal.pone.0127228.","journal-title":"PLoS ONE"},{"key":"1186_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0889-8561(03)00104-8","volume":"24","author":"C Bachert","year":"2004","unstructured":"Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am. 2004;24:19\u201343. https:\/\/doi.org\/10.1016\/S0889-8561(03)00104-8.","journal-title":"Immunol Allergy Clin North Am"},{"key":"1186_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13601-020-00332-z","volume":"10","author":"M Wang","year":"2020","unstructured":"Wang M, Bu X, Luan G, Lin L, Wang Y, Jin J, et al. Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma. Clin Transl Allergy. 2020;10:26. https:\/\/doi.org\/10.1186\/s13601-020-00332-z.","journal-title":"Clin Transl Allergy"},{"key":"1186_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaci.2022.04.013","volume":"150","author":"N Chapurin","year":"2022","unstructured":"Chapurin N, Wu J, Labby AB, Chandra RK, Chowdhury NI, Turner JH. Current insight into treatment of chronic rhinosinusitis: Phenotypes, endotypes, and implications for targeted therapeutics. J Allergy Clin Immunol. 2022;150:22\u201332. https:\/\/doi.org\/10.1016\/j.jaci.2022.04.013.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1939-4551-7-25","volume":"7","author":"C Bachert","year":"2014","unstructured":"Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7:25. https:\/\/doi.org\/10.1186\/1939-4551-7-25.","journal-title":"World Allergy Organ J"},{"key":"1186_CR19","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","volume":"9","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic Rhinosinusitis with Nasal Polyps and Asthma. J Allergy Clin Immunol. 2021;9:1133\u201341. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.063.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/cea.12472","volume":"45","author":"KE Hulse","year":"2015","unstructured":"Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal polyposis. Clin Experimental Allergy. 2015;45:328\u201346. https:\/\/doi.org\/10.1111\/cea.12472.","journal-title":"Clin Experimental Allergy"},{"key":"1186_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.jaip.2019.12.021","volume":"8","author":"SH Cho","year":"2020","unstructured":"Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of Chronic Rhinosinusitis. J Allergy Clin Immunol. 2020;8:1505\u201311. https:\/\/doi.org\/10.1016\/j.jaip.2019.12.021.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR22","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2147\/JAA.S437876","volume":"16","author":"C-C Huang","year":"2023","unstructured":"Huang C-C, Chang P-H, Huang Y-L, Lee T-J, Huang C-C, Wu P-W. Clinical Characteristics of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps in Adolescents. JAA. 2023;16:1197\u2013206. https:\/\/doi.org\/10.2147\/JAA.S437876.","journal-title":"JAA"},{"key":"1186_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ni805","volume":"3","author":"V Soumelis","year":"2002","unstructured":"Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell\u2013mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673\u201380. https:\/\/doi.org\/10.1038\/ni805.","journal-title":"Nat Immunol"},{"key":"1186_CR24","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4049\/jimmunol.167.1.336","volume":"167","author":"PA Reche","year":"2001","unstructured":"Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells. J Immunol. 2001;167:336\u201343. https:\/\/doi.org\/10.4049\/jimmunol.167.1.336.","journal-title":"J Immunol"},{"key":"1186_CR25","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1084\/jem.20051135","volume":"202","author":"T Ito","year":"2005","unstructured":"Ito T, Wang Y-H, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005;202:1213\u201323. https:\/\/doi.org\/10.1084\/jem.20051135.","journal-title":"J Exp Med"},{"key":"1186_CR26","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.21037\/jtd.2018.11.12","volume":"10","author":"Y Wei","year":"2018","unstructured":"Wei Y, Ma R, Zhang J, Wu X, Yu G, Hu X, et al. Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma. J Thorac Dis. 2018;10:6585\u201397. https:\/\/doi.org\/10.21037\/jtd.2018.11.12.","journal-title":"J Thorac Dis"},{"key":"1186_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-019-05379-8","author":"M Dogan","year":"2019","unstructured":"Dogan M, Sahin M, Yenisey C. Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp. Eur Arch Otorhinolaryngol. 2019. https:\/\/doi.org\/10.1007\/s00405-019-05379-8.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1186_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/MAJ.0b013e3181f20489","volume":"341","author":"T Liu","year":"2011","unstructured":"Liu T, Zhao F, Xie C, Liu A-M, Li T-L, Chen X, et al. Role of Thymic Stromal Lymphopoietin in the Pathogenesis of Nasal Polyposis. Am J Med Sci. 2011;341:40\u20137. https:\/\/doi.org\/10.1097\/MAJ.0b013e3181f20489.","journal-title":"Am J Med Sci"},{"key":"1186_CR29","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jaci.2022.11.029","volume":"151","author":"B-F Wang","year":"2023","unstructured":"Wang B-F, Cao P-P, Norton JE, Poposki JA, Klingler AI, Suh LA, et al. Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2023;151:1379-1390.e11. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.029.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/all.12667","volume":"70","author":"B Liao","year":"2015","unstructured":"Liao B, Cao P-P, Zeng M, Zhen Z, Wang H, Zhang Y-N, et al. Interaction of thymic stromal lymphopoietin, IL -33, and their receptors in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. Allergy. 2015;70:1169\u201380. https:\/\/doi.org\/10.1111\/all.12667.","journal-title":"Allergy"},{"key":"1186_CR31","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009;6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"1186_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","volume":"128","author":"PB Burns","year":"2011","unstructured":"Burns PB, Rohrich RJ, Chung KC. The Levels of Evidence and Their Role in Evidence-Based Medicine. Plast Reconstr Surg. 2011;128:305\u201310. https:\/\/doi.org\/10.1097\/PRS.0b013e318219c171.","journal-title":"Plast Reconstr Surg"},{"key":"1186_CR33","first-page":"321","volume":"22","author":"SL Friend","year":"1994","unstructured":"Friend SL, Hosier S, Nelson A, Foxworthe D, Williams DE, Farr A. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321\u20138.","journal-title":"Exp Hematol"},{"key":"1186_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1084\/jem.192.5.671","volume":"192","author":"JE Sims","year":"2000","unstructured":"Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, et al. Molecular Cloning and Biological Characterization of a Novel Murine Lymphoid Growth Factor. J Exp Med. 2000;192:671\u201380. https:\/\/doi.org\/10.1084\/jem.192.5.671.","journal-title":"J Exp Med"},{"key":"1186_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/eji.1830260103","volume":"26","author":"RJ Ray","year":"1996","unstructured":"Ray RJ, Furlonger C, Williams DE, Paige CJ. Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. Eur J Immunol. 1996;26:10\u20136. https:\/\/doi.org\/10.1002\/eji.1830260103.","journal-title":"Eur J Immunol"},{"key":"1186_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2332\/allergolint.11-RAI-0395","volume":"61","author":"T Takai","year":"2012","unstructured":"Takai T. TSLP Expression: Cellular Sources, Triggers, and Regulatory Mechanisms. Allergol Int. 2012;61:3\u201317. https:\/\/doi.org\/10.2332\/allergolint.11-RAI-0395.","journal-title":"Allergol Int"},{"key":"1186_CR37","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4049\/jimmunol.1100355","volume":"187","author":"M Kashyap","year":"2011","unstructured":"Kashyap M, Rochman Y, Spolski R, Samsel L, Leonard WJ. Thymic Stromal Lymphopoietin Is Produced by Dendritic Cells. J Immunol. 2011;187:1207\u201311. https:\/\/doi.org\/10.4049\/jimmunol.1100355.","journal-title":"J Immunol"},{"key":"1186_CR38","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/eji.201142123","volume":"42","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Zhou X, Zhou B. DC -derived TSLP promotes T h2 polarization in LPS -primed allergic airway inflammation. Eur J Immunol. 2012;42:1735\u201343. https:\/\/doi.org\/10.1002\/eji.201142123.","journal-title":"Eur J Immunol"},{"key":"1186_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cyto.2011.03.007","volume":"54","author":"P-D Moon","year":"2011","unstructured":"Moon P-D, Kim H-M. Thymic stromal lymphopoietin is expressed and produced by caspase-1\/NF-\u03baB pathway in mast cells. Cytokine. 2011;54:239\u201343. https:\/\/doi.org\/10.1016\/j.cyto.2011.03.007.","journal-title":"Cytokine"},{"key":"1186_CR40","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.4049\/jimmunol.181.4.2790","volume":"181","author":"S Ying","year":"2008","unstructured":"Ying S, O\u2019Connor B, Ratoff J, Meng Q, Fang C, Cousins D, et al. Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease. J Immunol. 2008;181:2790\u20138. https:\/\/doi.org\/10.4049\/jimmunol.181.4.2790.","journal-title":"J Immunol"},{"key":"1186_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1183\/09031936.00121008","volume":"34","author":"Y Okayama","year":"2009","unstructured":"Okayama Y, Okumura S, Sagara H, Yuki K, Sasaki T, Watanabe N, et al. Fc RI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells. Eur Respir J. 2009;34:425\u201335. https:\/\/doi.org\/10.1183\/09031936.00121008.","journal-title":"Eur Respir J"},{"key":"1186_CR42","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.jaci.2009.01.059","volume":"123","author":"Z Allakhverdi","year":"2009","unstructured":"Allakhverdi Z, Comeau MR, Jessup HK, Delespesse G. Thymic stromal lymphopoietin as a mediator of crosstalk between bronchial smooth muscles and mast cells. J Allergy Clin Immunol. 2009;123:958-60.e2. https:\/\/doi.org\/10.1016\/j.jaci.2009.01.059.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR43","doi-asserted-by":"publisher","first-page":"L375","DOI":"10.1152\/ajplung.00045.2007","volume":"293","author":"K Zhang","year":"2007","unstructured":"Zhang K, Shan L, Rahman MS, Unruh H, Halayko AJ, Gounni AS. Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2007;293:L375\u201382. https:\/\/doi.org\/10.1152\/ajplung.00045.2007.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1186_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/all.15609","volume":"78","author":"GM Gauvreau","year":"2023","unstructured":"Gauvreau GM, Bergeron C, Boulet L, Cockcroft DW, C\u00f4t\u00e9 A, Davis BE, et al. Sounding the alarmins\u2014The role of alarmin cytokines in asthma. Allergy. 2023;78:402\u201317. https:\/\/doi.org\/10.1111\/all.15609.","journal-title":"Allergy"},{"key":"1186_CR45","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1172\/JCI124606","volume":"129","author":"F Roan","year":"2019","unstructured":"Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell\u2013derived cytokines: more than just signaling the alarm. J Clin Investig. 2019;129:1441\u201351. https:\/\/doi.org\/10.1172\/JCI124606.","journal-title":"J Clin Investig"},{"key":"1186_CR46","doi-asserted-by":"publisher","first-page":"975914","DOI":"10.3389\/fimmu.2022.975914","volume":"13","author":"M Duchesne","year":"2022","unstructured":"Duchesne M, Okoye I, Lacy P. Epithelial cell alarmin cytokines: Frontline mediators of the asthma inflammatory response. Front Immunol. 2022;13:975914. https:\/\/doi.org\/10.3389\/fimmu.2022.975914.","journal-title":"Front Immunol"},{"key":"1186_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/76923","volume":"1","author":"A Pandey","year":"2000","unstructured":"Pandey A, Ozaki K, Baumann H, Levin SD, Puel A, Farr AG, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immunol. 2000;1:59\u201364. https:\/\/doi.org\/10.1038\/76923.","journal-title":"Nat Immunol"},{"key":"1186_CR48","doi-asserted-by":"publisher","first-page":"14937","DOI":"10.1038\/ncomms14937","volume":"8","author":"K Verstraete","year":"2017","unstructured":"Verstraete K, Peelman F, Braun H, Lopez J, Van Rompaey D, Dansercoer A, et al. Structure and antagonism of the receptor complex mediated by human TSLP in allergy and asthma. Nat Commun. 2017;8:14937. https:\/\/doi.org\/10.1038\/ncomms14937.","journal-title":"Nat Commun"},{"key":"1186_CR49","doi-asserted-by":"publisher","first-page":"19455","DOI":"10.1073\/pnas.1008271107","volume":"107","author":"Y Rochman","year":"2010","unstructured":"Rochman Y, Kashyap M, Robinson GW, Sakamoto K, Gomez-Rodriguez J, Wagner K-U, et al. Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7\u2013induced signaling. Proc Natl Acad Sci USA. 2010;107:19455\u201360. https:\/\/doi.org\/10.1073\/pnas.1008271107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1186_CR50","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20090153","volume":"206","author":"N Lu","year":"2009","unstructured":"Lu N, Wang Y-H, Wang Y-H, Arima K, Hanabuchi S, Liu Y-J. TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis. J Exp Med. 2009;206:2111\u20139. https:\/\/doi.org\/10.1084\/jem.20090153.","journal-title":"J Exp Med"},{"key":"1186_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ni.1852","volume":"11","author":"SF Ziegler","year":"2010","unstructured":"Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol. 2010;11:289\u201393. https:\/\/doi.org\/10.1038\/ni.1852.","journal-title":"Nat Immunol"},{"key":"1186_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1189\/jlb.1211622","volume":"91","author":"F Roan","year":"2012","unstructured":"Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012;91:877\u201386. https:\/\/doi.org\/10.1189\/jlb.1211622.","journal-title":"J Leukoc Biol"},{"key":"1186_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1084\/jem.20062211","volume":"204","author":"Z Allakhverdi","year":"2007","unstructured":"Allakhverdi Z, Comeau MR, Jessup HK, Yoon B-RP, Brewer A, Chartier S, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204:253\u20138. https:\/\/doi.org\/10.1084\/jem.20062211.","journal-title":"J Exp Med"},{"key":"1186_CR54","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000106319","volume":"144","author":"Y Nagata","year":"2007","unstructured":"Nagata Y, Kamijuku H, Taniguchi M, Ziegler S, Seino K. Differential Role of Thymic Stromal Lymphopoietin in the Induction of Airway Hyperreactivity and Th2 Immune Response in Antigen-Induced Asthma with Respect to Natural Killer T Cell Function. Int Arch Allergy Immunol. 2007;144:305\u201314. https:\/\/doi.org\/10.1159\/000106319.","journal-title":"Int Arch Allergy Immunol"},{"key":"1186_CR55","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1165\/rcmb.2009-0168OC","volume":"43","author":"CK Wong","year":"2010","unstructured":"Wong CK, Hu S, Cheung PFY, Lam CWK. Thymic Stromal Lymphopoietin Induces Chemotactic and Prosurvival Effects in Eosinophils: Implications in Allergic Inflammation. Am J Respir Cell Mol Biol. 2010;43:305\u201315. https:\/\/doi.org\/10.1165\/rcmb.2009-0168OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1186_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature10329","volume":"477","author":"MC Siracusa","year":"2011","unstructured":"Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA, et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 2011;477:229\u201333. https:\/\/doi.org\/10.1038\/nature10329.","journal-title":"Nature"},{"key":"1186_CR57","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","volume":"1","author":"A Camelo","year":"2017","unstructured":"Camelo A, Rosignoli G, Ohne Y, Stewart RA, Overed-Sayer C, Sleeman MA, et al. IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells. Blood Adv. 2017;1:577\u201389. https:\/\/doi.org\/10.1182\/bloodadvances.2016002352.","journal-title":"Blood Adv"},{"key":"1186_CR58","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.4049\/jimmunol.178.11.6720","volume":"178","author":"I Rochman","year":"2007","unstructured":"Rochman I, Watanabe N, Arima K, Liu Y-J, Leonard WJ. Cutting Edge: Direct Action of Thymic Stromal Lymphopoietin on Activated Human CD4+ T Cells. J Immunol. 2007;178:6720\u20134. https:\/\/doi.org\/10.4049\/jimmunol.178.11.6720.","journal-title":"J Immunol"},{"key":"1186_CR59","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1073\/pnas.1714348115","volume":"115","author":"S Ochiai","year":"2018","unstructured":"Ochiai S, Jagot F, Kyle RL, Hyde E, White RF, Prout M, et al. Thymic stromal lymphopoietin drives the development of IL-13 + Th2 cells. Proc Natl Acad Sci USA. 2018;115:1033\u20138. https:\/\/doi.org\/10.1073\/pnas.1714348115.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1186_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jcmgh.2017.01.005","volume":"3","author":"K Tsilingiri","year":"2017","unstructured":"Tsilingiri K, Fornasa G, Rescigno M. Thymic Stromal Lymphopoietin: To Cut a Long Story Short. Cell Mol Gastroenterol Hepatol. 2017;3:174\u201382. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.01.005.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1186_CR61","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1165\/rcmb.2008-0041OC","volume":"40","author":"M Harada","year":"2009","unstructured":"Harada M, Hirota T, Jodo AI, Doi S, Kameda M, Fujita K, et al. Functional Analysis of the Thymic Stromal Lymphopoietin Variants in Human Bronchial Epithelial Cells. Am J Respir Cell Mol Biol. 2009;40:368\u201374. https:\/\/doi.org\/10.1165\/rcmb.2008-0041OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1186_CR62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jaci.2015.04.011","volume":"136","author":"G Fornasa","year":"2015","unstructured":"Fornasa G, Tsilingiri K, Caprioli F, Botti F, Mapelli M, Meller S, et al. Dichotomy of short and long thymic stromal lymphopoietin isoforms in inflammatory disorders of the bowel and skin. J Allergy Clin Immunol. 2015;136:413\u201322. https:\/\/doi.org\/10.1016\/j.jaci.2015.04.011.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/mi.2014.41","volume":"8","author":"L Bjerkan","year":"2015","unstructured":"Bjerkan L, Schreurs O, Engen SA, Jahnsen FL, Baekkevold ES, Blix IJ, et al. The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide. Mucosal Immunol. 2015;8:49\u201356. https:\/\/doi.org\/10.1038\/mi.2014.41.","journal-title":"Mucosal Immunol"},{"key":"1186_CR64","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/nature03886","volume":"436","author":"N Watanabe","year":"2005","unstructured":"Watanabe N, Wang Y-H, Lee HK, Ito T, Wang Y-H, Cao W, et al. Hassall\u2019s corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005;436:1181\u20135. https:\/\/doi.org\/10.1038\/nature03886.","journal-title":"Nature"},{"key":"1186_CR65","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.0804106","volume":"184","author":"S Hanabuchi","year":"2010","unstructured":"Hanabuchi S, Ito T, Park W-R, Watanabe N, Shaw JL, Roman E, et al. Thymic Stromal Lymphopoietin-Activated Plasmacytoid Dendritic Cells Induce the Generation of FOXP3+ Regulatory T Cells in Human Thymus. J Immunol. 2010;184:2999\u20133007. https:\/\/doi.org\/10.4049\/jimmunol.0804106.","journal-title":"J Immunol"},{"key":"1186_CR66","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jdermsci.2012.03.007","volume":"66","author":"Y Xie","year":"2012","unstructured":"Xie Y, Takai T, Chen X, Okumura K, Ogawa H. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J Dermatol Sci. 2012;66:233\u20137. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.03.007.","journal-title":"J Dermatol Sci"},{"key":"1186_CR67","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.4049\/jimmunol.174.12.8183","volume":"174","author":"S Ying","year":"2005","unstructured":"Ying S, O\u2019Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, et al. Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity. J Immunol. 2005;174:8183\u201390. https:\/\/doi.org\/10.4049\/jimmunol.174.12.8183.","journal-title":"J Immunol"},{"key":"1186_CR68","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1164\/rccm.201712-2468LE","volume":"198","author":"D Al-Sajee","year":"2018","unstructured":"Al-Sajee D, Sehmi R, Hawke TJ, El-Gammal A, Howie KJ, Watson RM, et al. Expression of IL-33 and TSLP and Their Receptors in Asthmatic Airways after Inhaled Allergen Challenge. Am J Respir Crit Care Med. 2018;198:805\u20137. https:\/\/doi.org\/10.1164\/rccm.201712-2468LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"1186_CR69","doi-asserted-by":"publisher","unstructured":"Khanna K, Tang M, Fahy JV. Serum TSLP Levels in Asthma - Relationship to Type 2 and Non-Type 2 Biomarkers. A101. Linking biology to the real world in asthma and allergic inflammation, American Thoracic Society; 2023, p A2552\u2013A2552. https:\/\/doi.org\/10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A2552.","DOI":"10.1164\/ajrccm-conference.2023.207.1_MeetingAbstracts.A2552"},{"key":"1186_CR70","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2023.11.915","volume":"153","author":"LM Andreasson","year":"2024","unstructured":"Andreasson LM, Dyhre-Petersen N, Hvidtfeldt M, J\u00f8rgensen G\u00d8, Von B\u00fclow A, Klein DK, et al. Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation. J Allergy Clin Immunol. 2024;153:988-997.e11. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.915.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.imlet.2016.08.004","volume":"178","author":"A Berra\u00efes","year":"2016","unstructured":"Berra\u00efes A, Hamdi B, Ammar J, Hamzaoui K, Hamzaoui A. Increased expression of thymic stromal lymphopoietin in induced sputum from asthmatic children. Immunol Lett. 2016;178:85\u201391. https:\/\/doi.org\/10.1016\/j.imlet.2016.08.004.","journal-title":"Immunol Lett"},{"key":"1186_CR72","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4049\/jimmunol.1701455","volume":"200","author":"Y Li","year":"2018","unstructured":"Li Y, Wang W, Lv Z, Li Y, Chen Y, Huang K, et al. Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease. J Immunol. 2018;200:2253\u201362. https:\/\/doi.org\/10.4049\/jimmunol.1701455.","journal-title":"J Immunol"},{"key":"1186_CR73","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.4049\/jimmunol.1800709","volume":"201","author":"W Wang","year":"2018","unstructured":"Wang W, Li Y, Lv Z, Chen Y, Li Y, Huang K, et al. Bronchial Allergen Challenge of Patients with Atopic Asthma Triggers an Alarmin (IL-33, TSLP, and IL-25) Response in the Airways Epithelium and Submucosa. J Immunol. 2018;201:2221\u201331. https:\/\/doi.org\/10.4049\/jimmunol.1800709.","journal-title":"J Immunol"},{"key":"1186_CR74","doi-asserted-by":"publisher","first-page":"971073","DOI":"10.3389\/fped.2022.971073","volume":"10","author":"E Chorvinsky","year":"2022","unstructured":"Chorvinsky E, Nino G, Salka K, Gaviria S, Gutierrez MJ, Pillai DK. TSLP bronchoalveolar lavage levels at baseline are linked to clinical disease severity and reduced lung function in children with asthma. Front Pediatr. 2022;10:971073. https:\/\/doi.org\/10.3389\/fped.2022.971073.","journal-title":"Front Pediatr"},{"key":"1186_CR75","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/thx.2009.125930","volume":"65","author":"L Uller","year":"2010","unstructured":"Uller L, Leino M, Bedke N, Sammut D, Green B, Lau L, et al. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon- in bronchial epithelial cells from donors with asthma. Thorax. 2010;65:626\u201332. https:\/\/doi.org\/10.1136\/thx.2009.125930.","journal-title":"Thorax"},{"key":"1186_CR76","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","volume":"363","author":"MF Moffatt","year":"2010","unstructured":"Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, et al. A Large-Scale, Consortium-Based Genomewide Association Study of Asthma. N Engl J Med. 2010;363:1211\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0906312.","journal-title":"N Engl J Med"},{"key":"1186_CR77","doi-asserted-by":"publisher","unstructured":"Mexico City Childhood Asthma Study (MCAAS), Children\u2019s Health Study (CHS) and HARBORS study, Genetics of Asthma in Latino Americans (GALA) Study, the Study of Genes-Environment and Admixture in Latino Americans (GALA2) and the Study of African Americans, Asthma, Genes & Environments (SAGE), Childhood Asthma Research and Education (CARE) Network, Childhood Asthma Management Program (CAMP), Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE), et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011;43:887\u201392. https:\/\/doi.org\/10.1038\/ng.888.","DOI":"10.1038\/ng.888"},{"key":"1186_CR78","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1097\/MS9.0000000000002107","volume":"86","author":"AB Shrestha","year":"2024","unstructured":"Shrestha AB, Pokharel P, Singh H, Shrestha S, Shrestha S, Sedhai YR. Association between bronchial asthma and TSLP gene polymorphism: a systematic review and meta-analysis. Ann Med Surg. 2024;86:4684\u201394. https:\/\/doi.org\/10.1097\/MS9.0000000000002107.","journal-title":"Ann Med Surg"},{"key":"1186_CR79","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jaci.2009.04.018","volume":"124","author":"J-Q He","year":"2009","unstructured":"He J-Q, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, et al. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol. 2009;124:222\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2009.04.018.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR80","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ng.887","volume":"43","author":"T Hirota","year":"2011","unstructured":"Hirota T, Takahashi A, Kubo M, Tsunoda T, Tomita K, Doi S, et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet. 2011;43:893\u20136. https:\/\/doi.org\/10.1038\/ng.887.","journal-title":"Nat Genet"},{"key":"1186_CR81","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/j.1398-9995.2010.02415.x","volume":"65","author":"GM Hunninghake","year":"2010","unstructured":"Hunninghake GM, Soto-Quir\u00f3s ME, Avila L, Kim HP, Lasky-Su J, Rafaels N, et al. TSLP polymorphisms are associated with asthma in a sex-specific fashion. Allergy. 2010;65:1566\u201375. https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02415.x.","journal-title":"Allergy"},{"key":"1186_CR82","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1165\/rcmb.2009-0418OC","volume":"44","author":"M Harada","year":"2011","unstructured":"Harada M, Hirota T, Jodo AI, Hitomi Y, Sakashita M, Tsunoda T, et al. Thymic Stromal Lymphopoietin Gene Promoter Polymorphisms Are Associated with Susceptibility to Bronchial Asthma. Am J Respir Cell Mol Biol. 2011;44:787\u201393. https:\/\/doi.org\/10.1165\/rcmb.2009-0418OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1186_CR83","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000358488","volume":"163","author":"E Birben","year":"2014","unstructured":"Birben E, Sahiner UM, Karaaslan C, Yavuz TS, Cosgun E, Kalayci O, et al. The Genetic Variants of Thymic Stromal Lymphopoietin Protein in Children with Asthma and Allergic Rhinitis. Int Arch Allergy Immunol. 2014;163:185\u201392. https:\/\/doi.org\/10.1159\/000358488.","journal-title":"Int Arch Allergy Immunol"},{"key":"1186_CR84","doi-asserted-by":"publisher","first-page":"e25099","DOI":"10.1371\/journal.pone.0025099","volume":"6","author":"M Liu","year":"2011","unstructured":"Liu M, Rogers L, Cheng Q, Shao Y, Fernandez-Beros ME, Hirschhorn JN, et al. Genetic Variants of TSLP and Asthma in an Admixed Urban Population. PLoS ONE. 2011;6:e25099. https:\/\/doi.org\/10.1371\/journal.pone.0025099.","journal-title":"PLoS ONE"},{"key":"1186_CR85","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3390\/cells9051178","volume":"9","author":"Y Yasuda","year":"2020","unstructured":"Yasuda Y, Nagano T, Kobayashi K, Nishimura Y. Group 2 Innate Lymphoid Cells and the House Dust Mite-Induced Asthma Mouse Model. Cells. 2020;9:1178. https:\/\/doi.org\/10.3390\/cells9051178.","journal-title":"Cells"},{"key":"1186_CR86","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4049\/jimmunol.0900904","volume":"183","author":"H Kouzaki","year":"2009","unstructured":"Kouzaki H, O\u2019Grady SM, Lawrence CB, Kita H. Proteases Induce Production of Thymic Stromal Lymphopoietin by Airway Epithelial Cells through Protease-Activated Receptor-2. J Immunol. 2009;183:1427\u201334. https:\/\/doi.org\/10.4049\/jimmunol.0900904.","journal-title":"J Immunol"},{"key":"1186_CR87","doi-asserted-by":"publisher","unstructured":"Kale SL, Agrawal K, Gaur SN, Arora N. Cockroach protease allergen induces allergic airway inflammation via epithelial cell activation. Sci Rep 2017;7. https:\/\/doi.org\/10.1038\/srep42341.","DOI":"10.1038\/srep42341"},{"key":"1186_CR88","doi-asserted-by":"publisher","first-page":"8080","DOI":"10.1073\/pnas.96.14.8080","volume":"96","author":"SC Bischoff","year":"1999","unstructured":"Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci USA. 1999;96:8080\u20135. https:\/\/doi.org\/10.1073\/pnas.96.14.8080.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1186_CR89","doi-asserted-by":"publisher","unstructured":"Bax HJ, Keeble AH, Gould HJ. Cytokinergic IgE Action in Mast Cell Activation. Front Immun 2012;3. https:\/\/doi.org\/10.3389\/fimmu.2012.00229.","DOI":"10.3389\/fimmu.2012.00229"},{"key":"1186_CR90","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1378\/chest.11-1782","volume":"142","author":"D Kaur","year":"2012","unstructured":"Kaur D, Doe C, Woodman L, Heidi Wan W-Y, Sutcliffe A, Hollins F, et al. Mast Cell-Airway Smooth Muscle Crosstalk. Chest. 2012;142:76\u201385. https:\/\/doi.org\/10.1378\/chest.11-1782.","journal-title":"Chest"},{"key":"1186_CR91","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jaci.2012.04.019","volume":"130","author":"DR Nagarkar","year":"2012","unstructured":"Nagarkar DR, Poposki JA, Comeau MR, Biyasheva A, Avila PC, Schleimer RP, et al. Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin. J Allergy Clin Immunol. 2012;130:225-232.e4. https:\/\/doi.org\/10.1016\/j.jaci.2012.04.019.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR92","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaci.2014.06.024","volume":"134","author":"KR Bartemes","year":"2014","unstructured":"Bartemes KR, Kephart GM, Fox SJ, Kita H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134:671-678.e4. https:\/\/doi.org\/10.1016\/j.jaci.2014.06.024.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR93","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/14728222.2020.1783242","volume":"24","author":"GM Gauvreau","year":"2020","unstructured":"Gauvreau GM, Sehmi R, Ambrose CS, Griffiths JM. Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma. Expert Opin Ther Targets. 2020;24:777\u201392. https:\/\/doi.org\/10.1080\/14728222.2020.1783242.","journal-title":"Expert Opin Ther Targets"},{"key":"1186_CR94","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1476-7961-10-8","volume":"10","author":"EB Cook","year":"2012","unstructured":"Cook EB, Stahl JL, Schwantes EA, Fox KE, Mathur SK. IL-3 and TNF\u03b1 increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation. Clin Mol Allergy. 2012;10:8. https:\/\/doi.org\/10.1186\/1476-7961-10-8.","journal-title":"Clin Mol Allergy"},{"key":"1186_CR95","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1165\/rcmb.2016-0262OC","volume":"58","author":"BMA Salter","year":"2018","unstructured":"Salter BMA, Smith SG, Mukherjee M, Plante S, Krisna S, Nusca G, et al. Human Bronchial Epithelial Cell\u2013derived Factors from Severe Asthmatic Subjects Stimulate Eosinophil Differentiation. Am J Respir Cell Mol Biol. 2018;58:99\u2013106. https:\/\/doi.org\/10.1165\/rcmb.2016-0262OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1186_CR96","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jaci.2014.12.1918","volume":"135","author":"SG Smith","year":"2015","unstructured":"Smith SG, Gugilla A, Mukherjee M, Merim K, Irshad A, Tang W, et al. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J Allergy Clin Immunol. 2015;135:1594\u2013602. https:\/\/doi.org\/10.1016\/j.jaci.2014.12.1918.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR97","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/iid3.20","volume":"2","author":"CCK Hui","year":"2014","unstructured":"Hui CCK, Rusta-Sallehy S, Asher I, Heroux D, Denburg JA. The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil\u2013basophil lineage commitment: Relevance to atopic sensitization. Immunity Inflam & Disease. 2014;2:44\u201355. https:\/\/doi.org\/10.1002\/iid3.20.","journal-title":"Immunity Inflam & Disease"},{"key":"1186_CR98","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.anai.2022.02.021","volume":"129","author":"J Oppenheimer","year":"2022","unstructured":"Oppenheimer J, Hoyte FCL, Phipatanakul W, Silver J, Howarth P, Lugogo NL. Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions. Ann Allergy Asthma Immunol. 2022;129:169\u201380. https:\/\/doi.org\/10.1016\/j.anai.2022.02.021.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1186_CR99","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaci.2019.06.011","volume":"144","author":"Y Liang","year":"2019","unstructured":"Liang Y, Yu B, Chen J, Wu H, Xu Y, Yang B, et al. Thymic stromal lymphopoietin epigenetically upregulates Fc receptor \u03b3 subunit\u2013related receptors on antigen-presenting cells and induces TH2\/TH17 polarization through dectin-2. J Allergy Clin Immunol. 2019;144:1025-1035.e7. https:\/\/doi.org\/10.1016\/j.jaci.2019.06.011.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2222.2008.03151.x","volume":"39","author":"J Tanaka","year":"2009","unstructured":"Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, Nishio A, et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy. 2009;39:89\u2013100. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03151.x.","journal-title":"Clin Exp Allergy"},{"key":"1186_CR101","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-024-01462-9","volume":"44","author":"A Infante Cruz","year":"2024","unstructured":"Infante Cruz A, Coronel JV, Saibene V\u00e9lez P, Remes Lenicov F, Iturrizaga J, Abelleyro M, et al. Relevance of Thymic Stromal Lymphopoietin on the Pathogenesis of Glioblastoma: Role of the Neutrophil. Cell Mol Neurobiol. 2024;44:31. https:\/\/doi.org\/10.1007\/s10571-024-01462-9.","journal-title":"Cell Mol Neurobiol"},{"key":"1186_CR102","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.imbio.2017.05.010","volume":"222","author":"J Wieczfinska","year":"2017","unstructured":"Wieczfinska J, Pawliczak R. Thymic stromal lymphopoietin and apocynin alter the expression of airway remodeling factors in human rhinovirus-infected cells. Immunobiology. 2017;222:892\u20139. https:\/\/doi.org\/10.1016\/j.imbio.2017.05.010.","journal-title":"Immunobiology"},{"key":"1186_CR103","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/01902148.2018.1536175","volume":"44","author":"L Cao","year":"2018","unstructured":"Cao L, Liu F, Liu Y, Liu T, Wu J, Zhao J, et al. TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast. Exp Lung Res. 2018;44:288\u2013301. https:\/\/doi.org\/10.1080\/01902148.2018.1536175.","journal-title":"Exp Lung Res"},{"key":"1186_CR104","doi-asserted-by":"publisher","first-page":"e77795","DOI":"10.1371\/journal.pone.0077795","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu J, Dong F, Wang R-A, Wang J, Zhao J, Yang M, et al. Central Role of Cellular Senescence in TSLP-Induced Airway Remodeling in Asthma. PLoS ONE. 2013;8:e77795. https:\/\/doi.org\/10.1371\/journal.pone.0077795.","journal-title":"PLoS ONE"},{"key":"1186_CR105","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/srep02301","volume":"3","author":"NS Redhu","year":"2013","unstructured":"Redhu NS, Shan L, Movassagh H, Gounni AS. Thymic Stromal Lymphopoietin Induces Migration in Human Airway Smooth Muscle Cells. Sci Rep. 2013;3:2301. https:\/\/doi.org\/10.1038\/srep02301.","journal-title":"Sci Rep"},{"key":"1186_CR106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejim.2024.02.020","volume":"124","author":"L Can\u00e8","year":"2024","unstructured":"Can\u00e8 L, Poto R, Palestra F, Pirozzi M, Parashuraman S, Iacobucci I, et al. TSLP is localized in and released from human lung macrophages activated by T2-high and T2-low stimuli: relevance in asthma and COPD. Eur J Intern Med. 2024;124:89\u201398. https:\/\/doi.org\/10.1016\/j.ejim.2024.02.020.","journal-title":"Eur J Intern Med"},{"key":"1186_CR107","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/all.12809","volume":"71","author":"N Zhang","year":"2016","unstructured":"Zhang N, Van Crombruggen K, Gevaert E, Bachert C. Barrier function of the nasal mucosa in health and type-2 biased airway diseases. Allergy. 2016;71:295\u2013307. https:\/\/doi.org\/10.1111\/all.12809.","journal-title":"Allergy"},{"key":"1186_CR108","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/all.16064","volume":"79","author":"Z Huang","year":"2024","unstructured":"Huang Z, Liu J, Sun L, Ong HH, Ye J, Xu Y, et al. Updated epithelial barrier dysfunction in chronic rhinosinusitis: Targeting pathophysiology and treatment response of tight junctions. Allergy. 2024;79:1146\u201365. https:\/\/doi.org\/10.1111\/all.16064.","journal-title":"Allergy"},{"key":"1186_CR109","doi-asserted-by":"publisher","first-page":"12379","DOI":"10.3390\/ijms241512379","volume":"24","author":"K Petalas","year":"2023","unstructured":"Petalas K, Goudakos J, Konstantinou GN. Targeting Epithelium Dysfunction and Impaired Nasal Biofilms to Treat Immunological, Functional, and Structural Abnormalities of Chronic Rhinosinusitis. IJMS. 2023;24:12379. https:\/\/doi.org\/10.3390\/ijms241512379.","journal-title":"IJMS"},{"key":"1186_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2500\/ajra.2012.26.3716","volume":"26","author":"D Gudis","year":"2012","unstructured":"Gudis D, Zhao K-Q, Cohen NA. Acquired Cilia Dysfunction in Chronic Rhinosinusitis. Am J Rhinol Allergy. 2012;26:1\u20136. https:\/\/doi.org\/10.2500\/ajra.2012.26.3716.","journal-title":"Am J Rhinol Allergy"},{"key":"1186_CR111","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jaci.2012.05.052","volume":"130","author":"MB Soyka","year":"2012","unstructured":"Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, et al. Defective epithelial barrier in chronic rhinosinusitis: The regulation of tight junctions by IFN-\u03b3 and IL-4. J Allergy Clin Immunol. 2012;130:1087-1096.e10. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.052.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR112","doi-asserted-by":"publisher","first-page":"108031","DOI":"10.1016\/j.envint.2023.108031","volume":"177","author":"J Wang","year":"2023","unstructured":"Wang J, Shen S, Yan B, He Y, Zhang G, Shan C, et al. Individual exposure of ambient particulate matters and eosinophilic chronic rhinosinusitis with nasal Polyps: Dose-Response, mediation effects and recurrence prediction. Environ Int. 2023;177:108031. https:\/\/doi.org\/10.1016\/j.envint.2023.108031.","journal-title":"Environ Int"},{"key":"1186_CR113","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1398-9995.2011.02598.x","volume":"66","author":"R Vinhas","year":"2011","unstructured":"Vinhas R, Cortes L, Cardoso I, Mendes VM, Manadas B, Todo-Bom A, et al. Pollen proteases compromise the airway epithelial barrier through degradation of transmembrane adhesion proteins and lung bioactive peptides: Role of pollen proteases on allergic disorders. Allergy. 2011;66:1088\u201398. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02598.x.","journal-title":"Allergy"},{"key":"1186_CR114","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1398-9995.2005.00958.x","volume":"61","author":"H-Y Tai","year":"2006","unstructured":"Tai H-Y, Tam MF, Chou H, Peng H-J, Su S-N, Perng D-W, et al. Pen ch 13 allergen induces secretion of mediators and degradation of occludin protein of human lung epithelial cells. Allergy. 2006;61:382\u20138. https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00958.x.","journal-title":"Allergy"},{"key":"1186_CR115","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/all.15168","volume":"77","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Chen J, Hao Y, Wang B, Wang Y, Liu Q, et al. Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota. Allergy. 2022;77:540\u20139. https:\/\/doi.org\/10.1111\/all.15168.","journal-title":"Allergy"},{"key":"1186_CR116","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4193\/Rhino15.213","volume":"54","author":"F Lan","year":"2016","unstructured":"Lan F, Wang XD, Nauwynck HJ, Holtappels G, Zhang L, Johnston SL, et al. Th2 biased upper airway inflammation is associated with an impaired response to viral infection with Herpes simplex virus 1. Rhinology. 2016;54:141\u20139. https:\/\/doi.org\/10.4193\/Rhino15.213.","journal-title":"Rhinology"},{"key":"1186_CR117","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jaci.2023.01.030","volume":"151","author":"X Wang","year":"2023","unstructured":"Wang X, Hallen NR, Lee M, Samuchiwal S, Ye Q, Buchheit KM, et al. Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. J Allergy Clin Immunol. 2023;151:1536\u201349. https:\/\/doi.org\/10.1016\/j.jaci.2023.01.030.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR118","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jaci.2024.01.015","volume":"153","author":"B Yan","year":"2024","unstructured":"Yan B, Lan F, Li J, Wang C, Zhang L. The mucosal concept in chronic rhinosinusitis: Focus on the epithelial barrier. J Allergy Clin Immunol. 2024;153:1206\u201314. https:\/\/doi.org\/10.1016\/j.jaci.2024.01.015.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR119","doi-asserted-by":"publisher","first-page":"1354556","DOI":"10.3389\/fimmu.2024.1354556","volume":"15","author":"I Baglivo","year":"2024","unstructured":"Baglivo I, Colantuono S, Lumaca A, Papa A, Gasbarrini A, Caruso C. The last step to achieve barrier damage control. Front Immunol. 2024;15:1354556. https:\/\/doi.org\/10.3389\/fimmu.2024.1354556.","journal-title":"Front Immunol"},{"key":"1186_CR120","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.jaci.2015.09.005","volume":"136","author":"M Wang","year":"2015","unstructured":"Wang M, Wang X, Zhang N, Wang H, Li Y, Fan E, et al. Association of periostin expression with eosinophilic inflammation in nasal polyps. J Allergy Clin Immunol. 2015;136:1700-1703.e9. https:\/\/doi.org\/10.1016\/j.jaci.2015.09.005.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR121","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.3390\/jcm9113667","volume":"9","author":"P Nejman-Gryz","year":"2020","unstructured":"Nejman-Gryz P, G\u00f3rska K, Papli\u0144ska-Goryca M, Proboszcz M, Krenke R. Periostin and Thymic Stromal Lymphopoietin\u2014Potential Crosstalk in Obstructive Airway Diseases. JCM. 2020;9:3667. https:\/\/doi.org\/10.3390\/jcm9113667.","journal-title":"JCM"},{"key":"1186_CR122","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaci.2021.01.036","volume":"148","author":"D Wu","year":"2021","unstructured":"Wu D, Yan B, Wang Y, Wang C, Zhang L. Prognostic and pharmacologic value of cystatin SN for chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2021;148:450\u201360. https:\/\/doi.org\/10.1016\/j.jaci.2021.01.036.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR123","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4168\/aair.2011.3.3.186","volume":"3","author":"S Kimura","year":"2011","unstructured":"Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T, et al. Increased Expression and Role of Thymic Stromal Lymphopoietin in Nasal Polyposis. Allergy Asthma Immunol Res. 2011;3:186. https:\/\/doi.org\/10.4168\/aair.2011.3.3.186.","journal-title":"Allergy Asthma Immunol Res"},{"key":"1186_CR124","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/039463201102400322","volume":"24","author":"M Boita","year":"2011","unstructured":"Boita M, Garzaro M, Raimondo L, Riva G, Mazibrada J, Vizio B, et al. The Expression of TSLP Receptor in Chronic Rhinosinusitis with and without Nasal Polyps. Int J Immunopathol Pharmacol. 2011;24:761\u20138. https:\/\/doi.org\/10.1177\/039463201102400322.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1186_CR125","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1165\/rcmb.2017-0325OC","volume":"59","author":"Y Kato","year":"2018","unstructured":"Kato Y, Takabayashi T, Sakashita M, Imoto Y, Tokunaga T, Ninomiya T, et al. Expression and Functional Analysis of CST1 in Intractable Nasal Polyps. Am J Respir Cell Mol Biol. 2018;59:448\u201357. https:\/\/doi.org\/10.1165\/rcmb.2017-0325OC.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1186_CR126","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/alr.22226","volume":"9","author":"SK Mueller","year":"2019","unstructured":"Mueller SK, Nocera AL, Dillon ST, Gu X, Wendler O, Otu HH, et al. Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin-5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2019;9:177\u201386. https:\/\/doi.org\/10.1002\/alr.22226.","journal-title":"Int Forum Allergy Rhinol"},{"key":"1186_CR127","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/JAA.S315707","volume":"14","author":"H Deng","year":"2021","unstructured":"Deng H, Li M, Zheng R, Qiu H, Yuan T, Wang W, et al. YAP Promotes Cell Proliferation and Epithelium-Derived Cytokine Expression via NF-\u03baB Pathway in Nasal Polyps. JAA. 2021;14:839\u201350. https:\/\/doi.org\/10.2147\/JAA.S315707.","journal-title":"JAA"},{"key":"1186_CR128","doi-asserted-by":"publisher","first-page":"e0152808","DOI":"10.1371\/journal.pone.0152808","volume":"11","author":"K Golebski","year":"2016","unstructured":"Golebski K, Van Tongeren J, Van Egmond D, De Groot EJ, Fokkens WJ, Van Drunen CM. Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps. PLoS ONE. 2016;11:e0152808. https:\/\/doi.org\/10.1371\/journal.pone.0152808.","journal-title":"PLoS ONE"},{"key":"1186_CR129","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jaci.2004.07.013","volume":"114","author":"T Van Zele","year":"2004","unstructured":"Van Zele T, Gevaert P, Watelet J-B, Claeys G, Holtappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114:981\u20133. https:\/\/doi.org\/10.1016\/j.jaci.2004.07.013.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11882-019-0853-7","volume":"19","author":"TW Vickery","year":"2019","unstructured":"Vickery TW, Ramakrishnan VR, Suh JD. The Role of Staphylococcus aureus in Patients with Chronic Sinusitis and Nasal Polyposis. Curr Allergy Asthma Rep. 2019;19:21. https:\/\/doi.org\/10.1007\/s11882-019-0853-7.","journal-title":"Curr Allergy Asthma Rep"},{"key":"1186_CR131","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1164\/rccm.201710-2112OC","volume":"198","author":"F Lan","year":"2018","unstructured":"Lan F, Zhang N, Holtappels G, De Ruyck N, Krysko O, Van Crombruggen K, et al. Staphylococcus aureus Induces a Mucosal Type 2 Immune Response via Epithelial Cell\u2013derived Cytokines. Am J Respir Crit Care Med. 2018;198:452\u201363. https:\/\/doi.org\/10.1164\/rccm.201710-2112OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1186_CR132","doi-asserted-by":"publisher","first-page":"AB230","DOI":"10.1016\/j.jaci.2018.12.701","volume":"143","author":"SM Choi","year":"2019","unstructured":"Choi SM, DeConde A, Christiansen SC, Nizet V. Staphylococcus Aureus Induces IL-33, TSLP, and Muc5AC production by AERD Nasal Epithelium. J Allergy Clin Immunol. 2019;143:AB230. https:\/\/doi.org\/10.1016\/j.jaci.2018.12.701.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR133","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jaci.2020.01.027","volume":"145","author":"T Takabayashi","year":"2020","unstructured":"Takabayashi T, Schleimer RP. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin. J Allergy Clin Immunol. 2020;145:740\u201350. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.027.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR134","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/mi.2014.126","volume":"8","author":"CCK Hui","year":"2015","unstructured":"Hui CCK, Yu A, Heroux D, Akhabir L, Sandford AJ, Neighbour H, et al. Thymic stromal lymphopoietin (TSLP) secretion from human nasal epithelium is a function of TSLP genotype. Mucosal Immunol. 2015;8:993\u20139. https:\/\/doi.org\/10.1038\/mi.2014.126.","journal-title":"Mucosal Immunol"},{"key":"1186_CR135","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.alit.2019.06.007","volume":"69","author":"T Nakayama","year":"2020","unstructured":"Nakayama T, Hirota T, Asaka D, Sakashita M, Ninomiya T, Morikawa T, et al. A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations. Allergol Int. 2020;69:138\u201340. https:\/\/doi.org\/10.1016\/j.alit.2019.06.007.","journal-title":"Allergol Int"},{"key":"1186_CR136","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.humimm.2012.11.004","volume":"74","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang X, Zhang W, Han D, Zhang L, Bachert C. Polymorphisms in thymic stromal lymphopoietin gene demonstrate a gender and nasal polyposis-dependent association with chronic rhinosinusitis. Hum Immunol. 2013;74:241\u20138. https:\/\/doi.org\/10.1016\/j.humimm.2012.11.004.","journal-title":"Hum Immunol"},{"key":"1186_CR137","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13223-019-0389-3","volume":"15","author":"J Li","year":"2019","unstructured":"Li J, Jiao J, Gao Y, Zhang Y, Zhang L. Association between methylation in nasal epithelial TSLP gene and chronic rhinosinusitis with nasal polyps. Allergy Asthma Clin Immunol. 2019;15:71. https:\/\/doi.org\/10.1186\/s13223-019-0389-3.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1186_CR138","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jaci.2013.04.005","volume":"132","author":"DR Nagarkar","year":"2013","unstructured":"Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2013;132:593-600.e12. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.005.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR139","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jaci.2016.08.040","volume":"139","author":"JA Poposki","year":"2017","unstructured":"Poposki JA, Klingler AI, Stevens WW, Peters AT, Hulse KE, Grammer LC, et al. Proprotein convertases generate a highly functional heterodimeric form of thymic stromal lymphopoietin in humans. J Allergy Clin Immunol. 2017;139:1559-1567.e8. https:\/\/doi.org\/10.1016\/j.jaci.2016.08.040.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR140","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mj\u00f6sberg","year":"2012","unstructured":"Mj\u00f6sberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, et al. The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells. Immunity. 2012;37:649\u201359. https:\/\/doi.org\/10.1016\/j.immuni.2012.08.015.","journal-title":"Immunity"},{"key":"1186_CR141","doi-asserted-by":"publisher","first-page":"AB140","DOI":"10.1016\/j.jaci.2010.12.557","volume":"127","author":"P Cao","year":"2011","unstructured":"Cao P, Wang B, Zhang Y, You X, Gao Q, Cui Y, et al. TSLP Signaling and TH2-type Inflammation is Enhanced in Eosinophilic but not Noneosinophilic Nasal Polyps. J Allergy Clin Immunol. 2011;127:AB140. https:\/\/doi.org\/10.1016\/j.jaci.2010.12.557.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1186_CR142","doi-asserted-by":"publisher","first-page":"370","DOI":"10.4193\/Rhin17.045","volume":"56","author":"WW Wang","year":"2018","unstructured":"Wang WW, Lu DM, Zheng M, Zhang JG, Zhang B. TSLP regulates eotaxin-1 production by nasal epithelial cells from patients with eosinophilic CRSwNP. Rhinology. 2018;56(4):370\u20137. https:\/\/doi.org\/10.4193\/Rhin17.045.","journal-title":"Rhinology"},{"key":"1186_CR143","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.4049\/jimmunol.182.3.1404","volume":"182","author":"EAB Kelly","year":"2009","unstructured":"Kelly EAB, Koziol-White CJ, Clay KJ, Liu LY, Bates ME, Bertics PJ, et al. Potential Contribution of IL-7 to Allergen-Induced Eosinophilic Airway Inflammation in Asthma. J Immunol. 2009;182:1404\u201310. https:\/\/doi.org\/10.4049\/jimmunol.182.3.1404.","journal-title":"J Immunol"},{"key":"1186_CR144","doi-asserted-by":"publisher","first-page":"S250","DOI":"10.1016\/j.jaci.2008.12.964","volume":"123","author":"Y Hiraguchi","year":"2009","unstructured":"Hiraguchi Y, Hosoki K, Nagao M, Tokuda R, Fujisawa T. Thymic Stromal Lymphopoietin Directly Activates Eosinophils. J Allergy Clin Immunol. 2009;123:S250\u2013S250. https:\/\/doi.org\/10.1016\/j.jaci.2008.12.964.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR145","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1398-9995.2012.02868.x","volume":"67","author":"M Morshed","year":"2012","unstructured":"Morshed M, Yousefi S, St\u00f6ckle C, Simon H-U, Simon D. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy. 2012;67:1127\u201337. https:\/\/doi.org\/10.1111\/j.1398-9995.2012.02868.x.","journal-title":"Allergy"},{"key":"1186_CR146","doi-asserted-by":"publisher","first-page":"AB169","DOI":"10.1016\/j.jaci.2013.12.609","volume":"133","author":"D-K Kim","year":"2014","unstructured":"Kim D-K, Shin H-W, Park J-W, Yang M-S, Kim DW. The Role Of Innate Cytokine In Non-Asthmatic, Non-Eosinophilic Nasal Polyps: IL-25, IL-33 and TSLP. J Allergy Clin Immunol. 2014;133:AB169. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.609.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR147","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL, Parnes JR, She D, Crouch S, Rees W, Mo M, et al. Tezepelumab, an anti\u2013thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial. J Am Acad Dermatol. 2019;80:1013\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.059.","journal-title":"J Am Acad Dermatol"},{"key":"1186_CR148","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2147\/JAA.S342391","volume":"17","author":"R Panettieri Jr","year":"2024","unstructured":"Panettieri R Jr, Lugogo N, Corren J, Ambrose C. Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types. JAA. 2024;17:219\u201336. https:\/\/doi.org\/10.2147\/JAA.S342391.","journal-title":"JAA"},{"key":"1186_CR149","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, et al. Tezepelumab in Adults with Uncontrolled Asthma. N Engl J Med. 2017;377:936\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1704064.","journal-title":"N Engl J Med"},{"key":"1186_CR150","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1164\/rccm.202210-2005OC","volume":"208","author":"J Corren","year":"2023","unstructured":"Corren J, Menzies-Gow A, Chupp G, Israel E, Korn S, Cook B, et al. Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials. Am J Respir Crit Care Med. 2023;208:13\u201324. https:\/\/doi.org\/10.1164\/rccm.202210-2005OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1186_CR151","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1007\/s12325-024-02889-8","volume":"41","author":"TF Carr","year":"2024","unstructured":"Carr TF, Moore WC, Kraft M, Brusselle G, Castro M, Chupp GL, et al. Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study. Adv Ther. 2024;41:2978\u201390. https:\/\/doi.org\/10.1007\/s12325-024-02889-8.","journal-title":"Adv Ther"},{"key":"1186_CR152","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1007\/s12325-023-02659-y","volume":"40","author":"A Menzies-Gow","year":"2023","unstructured":"Menzies-Gow A, Ambrose CS, Colice G, Hunter G, Cook B, Molfino NA, et al. Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study. Adv Ther. 2023;40:4957\u201371. https:\/\/doi.org\/10.1007\/s12325-023-02659-y.","journal-title":"Adv Ther"},{"key":"1186_CR153","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/all.15918","volume":"79","author":"A Sverrild","year":"2024","unstructured":"Sverrild A, Cerps S, Nieto-Fontarigo JJ, Ramu S, Hvidtfeldt M, Menzel M, et al. Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma. Allergy. 2024;79:656\u201366. https:\/\/doi.org\/10.1111\/all.15918.","journal-title":"Allergy"},{"key":"1186_CR154","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","volume":"9","author":"S Diver","year":"2021","unstructured":"Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, et al. Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021;9:1299\u2013312. https:\/\/doi.org\/10.1016\/S2213-2600(21)00226-5.","journal-title":"Lancet Respir Med"},{"key":"1186_CR155","doi-asserted-by":"publisher","unstructured":"Nordenmark LH, Hellqvist \u00c5, Emson C, Diver S, Porsbjerg C, Griffiths JM, et al. Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe Asthma. NEJM Evidence 2023;2. https:\/\/doi.org\/10.1056\/EVIDoa2300135.","DOI":"10.1056\/EVIDoa2300135"},{"key":"1186_CR156","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12931-020-01503-z","volume":"21","author":"ME Wechsler","year":"2020","unstructured":"Wechsler ME, Colice G, Griffiths JM, Almqvist G, Sk\u00e4rby T, Piechowiak T, et al. SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma. Respir Res. 2020;21:264. https:\/\/doi.org\/10.1186\/s12931-020-01503-z.","journal-title":"Respir Res"},{"key":"1186_CR157","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S2213-2600(21)00537-3","volume":"10","author":"ME Wechsler","year":"2022","unstructured":"Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, et al. Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study. Lancet Respir Med. 2022;10:650\u201360. https:\/\/doi.org\/10.1016\/S2213-2600(21)00537-3.","journal-title":"Lancet Respir Med"},{"key":"1186_CR158","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12931-020-01541-7","volume":"21","author":"A Menzies-Gow","year":"2020","unstructured":"Menzies-Gow A, Ponnarambil S, Downie J, Bowen K, Hellqvist \u00c5, Colice G. DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma. Respir Res. 2020;21:279. https:\/\/doi.org\/10.1186\/s12931-020-01541-7.","journal-title":"Respir Res"},{"key":"1186_CR159","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2213-2600(22)00492-1","volume":"11","author":"A Menzies-Gow","year":"2023","unstructured":"Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, et al. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. Lancet Respir Med. 2023;11:425\u201338. https:\/\/doi.org\/10.1016\/S2213-2600(22)00492-1.","journal-title":"Lancet Respir Med"},{"key":"1186_CR160","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/JAA.S413064","volume":"16","author":"TM Laidlaw","year":"2023","unstructured":"Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E, et al. Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR. JAA. 2023;16:915\u201332. https:\/\/doi.org\/10.2147\/JAA.S413064.","journal-title":"JAA"},{"key":"1186_CR161","doi-asserted-by":"publisher","first-page":"1207641","DOI":"10.3389\/fimmu.2023.1207641","volume":"14","author":"J Plichta","year":"2023","unstructured":"Plichta J, Kuna P, Panek M. Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives. Front Immunol. 2023;14:1207641. https:\/\/doi.org\/10.3389\/fimmu.2023.1207641.","journal-title":"Front Immunol"},{"key":"1186_CR162","unstructured":"Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma (n.d.). ClinicalTrials.gov. Retrieved September 26, 2024, from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04410523."},{"key":"1186_CR163","doi-asserted-by":"publisher","first-page":"AB20","DOI":"10.1016\/j.jaci.2022.12.065","volume":"151","author":"X Tian","year":"2023","unstructured":"Tian X, Zhang X. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Human Monoclonal Antibody TQC2731 Targeting Thymic Stromal Lymphopoietin in Healthy Adults: A First-in-human, Randomized, Placebo-controlled, Double-blind, Phase 1 Study. J Allergy Clin Immunol. 2023;151:AB20. https:\/\/doi.org\/10.1016\/j.jaci.2022.12.065.","journal-title":"J Allergy Clin Immunol"},{"key":"1186_CR164","unstructured":"Dupixent Summary of Product Characteristics (n.d.).\u00a0European Medicines Agency. Retrieved September 26, from https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/dupixent-epar-product-information_en.pdf."},{"key":"1186_CR165","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5415\/apallergy.0000000000000135","volume":"14","author":"S Shen","year":"2024","unstructured":"Shen S, Xian M, Yan B, Lan F, Wang C, Zhang L. Anti-thymic stromal lymphopoietin monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps (DUBHE): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled study. Asia Pac Allergy. 2024;14:26\u201331. https:\/\/doi.org\/10.5415\/apallergy.0000000000000135.","journal-title":"Asia Pac Allergy"},{"key":"1186_CR166","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4193\/Rhin22.412","volume":"61","author":"HH Kariyawasam","year":"2023","unstructured":"Kariyawasam HH, Chandrasekharan DP, Jacques T, Stokes P, Dziadzio M, Gane SB, et al. Biologic treatment for severe chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Rhinology. 2023;61:98\u2013107. https:\/\/doi.org\/10.4193\/Rhin22.412.","journal-title":"Rhinology"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-024-01186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-024-01186-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-024-01186-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:57:08Z","timestamp":1733396228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-024-01186-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s11882-024-01186-2","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"4 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights Statement"}},{"value":"E. De Corso received lecture fees and participated to advisory boards for Sanofi, GSK, Regeneron, Astrazeneca. P. W. Hellings has received unrestricted research grants from Sanofi\/Regeneron, Viatris and GSK, and honoraria for lectures and\/or advisory boards by Sanofi\/Regeneron, GSK, and AstraZeneca. W. J. Fokkens received consultation and\/or speaker fees from Dianosic, GSK, Menarini, Novartis, Sanofi-Aventis\/Regeneron and AstraZeneca. The department of Otorhinolaryngology of the Amsterdam University Medical Centre, location AMC, received grants for research in Rhinology from: Novartis, EU, GSK, and Sanofi-Aventis. L. Klimek reports grants from Allergopharma, MEDA\/Mylan, ALK Abello\u0301, LETI Pharma, Stallergenes, Sanofi, ASIT biotech, Lofarma Quintiles, AstraZeneca, GSK, and Inmunotk; and personal fees from Allergopharma, MEDA\/Mylan, HAL Allergie, LETI Pharma, Sanofi, Allergy Therapeut, and Cassella Med, outside the submitted work. A. T. Peters has received research grants from Sanofi\/Regeneron and AstraZeneca. She has served as a consultant for GSK, Chiesi, Merck, Sanofi Regeneron, Eli Lilly and AstraZeneca. G. K. Scadding received honoraria for articles, speaker and advisory boards: ALK, Bayer, Chiesi, GSK, Haleon, Noucor, Sanofi- Regeneron, and Viatris. Chair of BSACI rhinitis guidelines, Scientific Chief Editor, Rhinology Section of Frontiers in Allergy, Vice President and AR lead for EUFOREA, and Chair\/ member Data Monitoring Committees on SLIT for ALK. M. Desrosiers received fee for consultation, speaker activity, advisory board by sanofi\/ Regeneron, GSK. He also received research support from Sanofi\/Regeneron, GSK. Equity holder, Probionase Therapies Inc. S. E. Lee has received clinical trial funding and served on advisory boards for AstraZeneca, Genentech, Lyra Therapeutics, GSK, Optinose, Sanofi Regeneron, Upstream Bio and holds equity in Diceros Therapeutics. J. Mullol reports personal fees and other from SANOFI-GENZYME & REGENERON, personal fees and other from NOVARTIS, grants, personal fees and other from VIATRIS \/ MEDA Pharma, grants and personal fees from NOUCOR \/ URIACH Group, personal fees from Menarini, personal fees from UCB, personal fees and other from AstraZeneca, grants, personal fees and other from GSK, personal fees from MSD, personal fees and other from Lilly, personal fees and other from GLENMARK, outside the submitted work. J. Mullol is a Section Editor of Current Allergy and Asthma Reports and was not involved in the peer-review or handling of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7"}}